From professional translators, enterprises, web pages and freely available translation repositories.
xelox
n=251; itt **:
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
xelox jew
xelox eller
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
xelox+ bevacizumab
xelox+ bevacizumab
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
folfox- 4 jew xelox
folfox- 4 folfox- 4
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
fl- ewwel Ġurnata, qabel xelox, q 3 ġimgħat
dag 1, före xelox, var tredje vecka
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
paragun ta ’ xelox u bevacizumab kontra folfox- 4 u bevacizumab kien analiżi esploratorju speċifikat minn qabel.
en jämförelse mellan xelox plus bevacizumab jämfört med folfox- 4 plus bevacizumab var en förspecificerad exploratorisk analys.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
ir- riżultati jindikaw li xelox huwa ekwivalenti għal folfox- 4 f’ termini ta ’ sopravivenza globali (ara tabella 8).
tabell 8
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
sopravivenza mingħajr progressjoni wara 6 xhur fil- popolazzjoni b’ intenzjoni li jiġu kkurati kienet 80% (xeliri u bevacizumab) kontra 74% (xelox u bevacizumab).
progressionsfri överlevnad vid 6 månader i ” intent- to- treat ” - populationen var 80% (xeliri plus bevacizumab) jämfört med 74% (xelox plus bevacizumab).
Last Update: 2012-04-10
Usage Frequency: 4
Quality:
